You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
諾誠健華(09969.HK)一季度總營業收入3.81億元 同比增長129.92%
格隆匯 05-13 20:15

格隆匯5月13日丨諾誠健華(09969.HK)公吿,2025年1-3月公司實現總營業收入3.81億元,比上年同期增長129.92%,毛利率為90.5%,比上年同期的85.4%提高了5.1個百分點。營業收入與毛利率的高速增長主要為核心產品奧布替尼(宜諾凱)銷售收入持續增長以及公司與Prolium Bioscience Inc.達成授權許可的首付款所致。公司2025年1-3月的淨利潤為0.14億元,與上年同期相比實現盈利。

2025年1-3月公司核心產品奧布替尼(宜諾凱)銷售收入持續增長,共實現銷售收入3.11億元,同比增長89.22%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account